The Europe Cell-based Assays Market would witness market growth of 7.7% CAGR during the forecast period (2022-2028).
The facilitation and creation of complicated and physiologically relevant data are two examples of the benefits that can be gained from using cell-based assays. Cell-based assays, in contrast to more classic biochemical ones, are more physiologically essential and have the ability to examine compound properties simultaneously. Assays that measure cell viability or proliferation are both useful tools for determining whether or not a cell is healthy.
Dye assays, utilizing substances, like trypan blue or Calcein-AM, or readouts based on fluorescent light are frequently used to evaluate cellular viability and proliferation rate. These tests can be utilized to determine the number of mammalian cell lines, primary cells, and stem cells, as well as their overall state of health. The process of cell migration involves the movement of cells in response to certain external cues. These signals might be chemical or mechanical in nature.
During the process of cell invasion, cells have the ability to alter their surroundings as they move through the three-dimensional architecture of the extracellular matrix. In vitro evaluation of cell invasion and movement is possible using membrane-based migration methods, such as the Boyden Chamber test. These technologies are quite common and widely utilized. In cancer research, cell migration and invasion kits are frequently used to evaluate cell motility along with invasiveness in response to chemotactic gradients.
The production of new blood vessels from preexisting vasculature is referred to as angiogenesis. This process is governed by chemical signals. In in vitro cell models, angiogenesis can be induced or inhibited, and the assays for this process can be used to examine either of these processes. The creation of cell-based assays for the purpose of drug discovery helps speed up the optimization of therapeutics for cancer as well as other diseases that are dependent on angiogenesis.
The research and development industry in European countries is highly robust. According to the Organization for Economic Co-operation and Development Library, Europe consists of 21 OECD countries that are also members of the European Union, in addition to Iceland, Norway, and Switzerland. The government's funds for research and development, or GBARD, include both the R&D that is carried out directly by the government and the sums that are given to other institutions for R&D. Research and development (R&D) in the area of health pertains to GBARD's efforts to protect, promote, and restore human health, which encompasses all facets of medical and social care.
The Germany market dominated the Europe Cell-based Assays Market by Country in 2021; thereby, achieving a market value of $1.6 billion by 2028. The UK market is exhibiting a CAGR of 6.9% during (2022 - 2028). Additionally, The France market would experience a CAGR of 8.5% during (2022 - 2028).
Based on Application, the market is segmented into Drug Discovery, Basic Research and Others. Based on End User, the market is segmented into Pharmaceutical & Biotechnology Companies, Academic & Research Institutes and Contract Research Organizations (CROs). Based on Products & Services, the market is segmented into Assay Kits, Reagents, Microplates, Probes & Labels, Instruments & Software and Cell Lines. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Global Cell-based Assays Market will Hit $24.9 Billion by 2028, at a CAGR of 8.2%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Corning Incorporated, Charles River Laboratories International, Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd., Lonza Group AG, Merck Group, Promega Corporation and Thermo Fisher Scientific, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Application
- Drug Discovery
- Basic Research
- Others
By End User
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- Contract Research Organizations (CROs)
By Products & Services
- Assay Kits
- Reagents
- Microplates
- Probes & Labels
- Instruments & Software
- Cell Lines
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Key Market Players
List of Companies Profiled in the Report:
- Becton, Dickinson and Company
- Bio-Rad Laboratories, Inc.
- Corning Incorporated
- Charles River Laboratories International, Inc.
- Danaher Corporation
- F. Hoffmann-La Roche Ltd.
- Lonza Group AG
- Merck Group
- Promega Corporation
- Thermo Fisher Scientific, Inc.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Cell-based Assays Market, by Application
1.4.2 Europe Cell-based Assays Market, by End User
1.4.3 Europe Cell-based Assays Market, by Products & Services
1.4.4 Europe Cell-based Assays Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition and scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Geographical Expansions
3.2.5 Approvals and Trials
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.3.2 Key Strategic Move: (Product Launches and Product Expansions : 2018, Jun – 2021, Jun) Leading Players
Chapter 4. Europe Cell-based Assays Market by Application
4.1 Europe Drug Discovery Market by Country
4.2 Europe Basic Research Market by Country
4.3 Europe Others Market by Country
Chapter 5. Europe Cell-based Assays Market by End-use
5.1 Europe Pharmaceutical & Biotechnology Companies Market by Country
5.2 Europe Academic & Research Institutes Market by Country
5.3 Europe Contract Research Organizations (CROs) Market by Country
Chapter 6. Europe Cell-based Assays Market by Products & Services
6.1 Europe Assay Kits Market by Country
6.2 Europe Reagents Market by Country
6.3 Europe Microplates Market by Country
6.4 Europe Probes & Labels Market by Country
6.5 Europe Instruments & Software Market by Country
6.6 Europe Cell Lines Market by Country
Chapter 7. Europe Cell-based Assays Market by Country
7.1 Germany Cell-based Assays Market
7.1.1 Germany Cell-based Assays Market by Application
7.1.2 Germany Cell-based Assays Market by End-use
7.1.3 Germany Cell-based Assays Market by Products & Services
7.2 UK Cell-based Assays Market
7.2.1 UK Cell-based Assays Market by Application
7.2.2 UK Cell-based Assays Market by End-use
7.2.3 UK Cell-based Assays Market by Products & Services
7.3 France Cell-based Assays Market
7.3.1 France Cell-based Assays Market by Application
7.3.2 France Cell-based Assays Market by End-use
7.3.3 France Cell-based Assays Market by Products & Services
7.4 Russia Cell-based Assays Market
7.4.1 Russia Cell-based Assays Market by Application
7.4.2 Russia Cell-based Assays Market by End-use
7.4.3 Russia Cell-based Assays Market by Products & Services
7.5 Spain Cell-based Assays Market
7.5.1 Spain Cell-based Assays Market by Application
7.5.2 Spain Cell-based Assays Market by End-use
7.5.3 Spain Cell-based Assays Market by Products & Services
7.6 Italy Cell-based Assays Market
7.6.1 Italy Cell-based Assays Market by Application
7.6.2 Italy Cell-based Assays Market by End-use
7.6.3 Italy Cell-based Assays Market by Products & Services
7.7 Rest of Europe Cell-based Assays Market
7.7.1 Rest of Europe Cell-based Assays Market by Application
7.7.2 Rest of Europe Cell-based Assays Market by End-use
7.7.3 Rest of Europe Cell-based Assays Market by Products & Services
Chapter 8. Company Profiles
8.1 Becton, Dickinson and Company
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.1.5.2 Product Launches and Product Expansions:
8.1.5.3 Acquisition and Mergers:
8.2 F. Hoffmann-La Roche Ltd.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.2.5.2 Product Launches and Product Expansions:
8.2.5.3 Acquisition and Mergers:
8.2.5.4 Approvals and Trials:
8.3 Thermo Fisher Scientific, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.3.5.2 Geographical Expansions:
8.4 Bio-Rad laboratories, Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expenses
8.4.5 Recent strategies and developments:
8.4.5.1 Partnerships, Collaborations, and Agreements:
8.4.5.2 Acquisition and Mergers:
8.5 Charles River Laboratories International, Inc.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Recent strategies and developments:
8.5.4.1 Partnerships, Collaborations, and Agreements:
8.5.4.2 Acquisition and Mergers:
8.6 Danaher Corporation
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expense
8.6.5 Recent strategies and developments:
8.6.5.1 Product Launches and Product Expansions:
8.7 Merck Group
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.7.5 Recent strategies and developments:
8.7.5.1 Partnerships, Collaborations, and Agreements:
8.8 Lonza Group AG
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expenses
8.8.5 Recent strategies and developments:
8.8.5.1 Partnerships, Collaborations, and Agreements:
8.9 Corning Incorporated
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expenses
8.9.5 Recent strategies and developments:
8.9.5.1 Product Launches and Product Expansions:
8.10. Promega Corporation
8.10.1 Company Overview
8.10.2 Recent strategies and developments:
8.10.2.1 Partnerships, Collaborations, and Agreements:
8.10.2.2 Product Launches and Product Expansions:
TABLE 1 Europe Cell-based Assays Market, 2018 - 2021, USD Million
TABLE 2 Europe Cell-based Assays Market, 2022 - 2028, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Cell-based Assays Market
TABLE 4 Product Launches And Product Expansions– Cell-based Assays Market
TABLE 5 Acquisition and Mergers– Cell-based Assays Market
TABLE 6 Geographical Expansions – Cell-based Assays Market
TABLE 7 Approvals and Trials – Cell-based Assays Market
TABLE 8 Europe Cell-based Assays Market by Application, 2018 - 2021, USD Million
TABLE 9 Europe Cell-based Assays Market by Application, 2022 - 2028, USD Million
TABLE 10 Europe Drug Discovery Market by Country, 2018 - 2021, USD Million
TABLE 11 Europe Drug Discovery Market by Country, 2022 - 2028, USD Million
TABLE 12 Europe Basic Research Market by Country, 2018 - 2021, USD Million
TABLE 13 Europe Basic Research Market by Country, 2022 - 2028, USD Million
TABLE 14 Europe Others Market by Country, 2018 - 2021, USD Million
TABLE 15 Europe Others Market by Country, 2022 - 2028, USD Million
TABLE 16 Europe Cell-based Assays Market by End-use, 2018 - 2021, USD Million
TABLE 17 Europe Cell-based Assays Market by End-use, 2022 - 2028, USD Million
TABLE 18 Europe Pharmaceutical & Biotechnology Companies Market by Country, 2018 - 2021, USD Million
TABLE 19 Europe Pharmaceutical & Biotechnology Companies Market by Country, 2022 - 2028, USD Million
TABLE 20 Europe Academic & Research Institutes Market by Country, 2018 - 2021, USD Million
TABLE 21 Europe Academic & Research Institutes Market by Country, 2022 - 2028, USD Million
TABLE 22 Europe Contract Research Organizations (CROs) Market by Country, 2018 - 2021, USD Million
TABLE 23 Europe Contract Research Organizations (CROs) Market by Country, 2022 - 2028, USD Million
TABLE 24 Europe Cell-based Assays Market by Products & Services, 2018 - 2021, USD Million
TABLE 25 Europe Cell-based Assays Market by Products & Services, 2022 - 2028, USD Million
TABLE 26 Europe Assay Kits Market by Country, 2018 - 2021, USD Million
TABLE 27 Europe Assay Kits Market by Country, 2022 - 2028, USD Million
TABLE 28 Europe Reagents Market by Country, 2018 - 2021, USD Million
TABLE 29 Europe Reagents Market by Country, 2022 - 2028, USD Million
TABLE 30 Europe Microplates Market by Country, 2018 - 2021, USD Million
TABLE 31 Europe Microplates Market by Country, 2022 - 2028, USD Million
TABLE 32 Europe Probes & Labels Market by Country, 2018 - 2021, USD Million
TABLE 33 Europe Probes & Labels Market by Country, 2022 - 2028, USD Million
TABLE 34 Europe Instruments & Software Market by Country, 2018 - 2021, USD Million
TABLE 35 Europe Instruments & Software Market by Country, 2022 - 2028, USD Million
TABLE 36 Europe Cell Lines Market by Country, 2018 - 2021, USD Million
TABLE 37 Europe Cell Lines Market by Country, 2022 - 2028, USD Million
TABLE 38 Europe Cell-based Assays Market by Country, 2018 - 2021, USD Million
TABLE 39 Europe Cell-based Assays Market by Country, 2022 - 2028, USD Million
TABLE 40 Germany Cell-based Assays Market, 2018 - 2021, USD Million
TABLE 41 Germany Cell-based Assays Market, 2022 - 2028, USD Million
TABLE 42 Germany Cell-based Assays Market by Application, 2018 - 2021, USD Million
TABLE 43 Germany Cell-based Assays Market by Application, 2022 - 2028, USD Million
TABLE 44 Germany Cell-based Assays Market by End-use, 2018 - 2021, USD Million
TABLE 45 Germany Cell-based Assays Market by End-use, 2022 - 2028, USD Million
TABLE 46 Germany Cell-based Assays Market by Products & Services, 2018 - 2021, USD Million
TABLE 47 Germany Cell-based Assays Market by Products & Services, 2022 - 2028, USD Million
TABLE 48 UK Cell-based Assays Market, 2018 - 2021, USD Million
TABLE 49 UK Cell-based Assays Market, 2022 - 2028, USD Million
TABLE 50 UK Cell-based Assays Market by Application, 2018 - 2021, USD Million
TABLE 51 UK Cell-based Assays Market by Application, 2022 - 2028, USD Million
TABLE 52 UK Cell-based Assays Market by End-use, 2018 - 2021, USD Million
TABLE 53 UK Cell-based Assays Market by End-use, 2022 - 2028, USD Million
TABLE 54 UK Cell-based Assays Market by Products & Services, 2018 - 2021, USD Million
TABLE 55 UK Cell-based Assays Market by Products & Services, 2022 - 2028, USD Million
TABLE 56 France Cell-based Assays Market, 2018 - 2021, USD Million
TABLE 57 France Cell-based Assays Market, 2022 - 2028, USD Million
TABLE 58 France Cell-based Assays Market by Application, 2018 - 2021, USD Million
TABLE 59 France Cell-based Assays Market by Application, 2022 - 2028, USD Million
TABLE 60 France Cell-based Assays Market by End-use, 2018 - 2021, USD Million
TABLE 61 France Cell-based Assays Market by End-use, 2022 - 2028, USD Million
TABLE 62 France Cell-based Assays Market by Products & Services, 2018 - 2021, USD Million
TABLE 63 France Cell-based Assays Market by Products & Services, 2022 - 2028, USD Million
TABLE 64 Russia Cell-based Assays Market, 2018 - 2021, USD Million
TABLE 65 Russia Cell-based Assays Market, 2022 - 2028, USD Million
TABLE 66 Russia Cell-based Assays Market by Application, 2018 - 2021, USD Million
TABLE 67 Russia Cell-based Assays Market by Application, 2022 - 2028, USD Million
TABLE 68 Russia Cell-based Assays Market by End-use, 2018 - 2021, USD Million
TABLE 69 Russia Cell-based Assays Market by End-use, 2022 - 2028, USD Million
TABLE 70 Russia Cell-based Assays Market by Products & Services, 2018 - 2021, USD Million
TABLE 71 Russia Cell-based Assays Market by Products & Services, 2022 - 2028, USD Million
TABLE 72 Spain Cell-based Assays Market, 2018 - 2021, USD Million
TABLE 73 Spain Cell-based Assays Market, 2022 - 2028, USD Million
TABLE 74 Spain Cell-based Assays Market by Application, 2018 - 2021, USD Million
TABLE 75 Spain Cell-based Assays Market by Application, 2022 - 2028, USD Million
TABLE 76 Spain Cell-based Assays Market by End-use, 2018 - 2021, USD Million
TABLE 77 Spain Cell-based Assays Market by End-use, 2022 - 2028, USD Million
TABLE 78 Spain Cell-based Assays Market by Products & Services, 2018 - 2021, USD Million
TABLE 79 Spain Cell-based Assays Market by Products & Services, 2022 - 2028, USD Million
TABLE 80 Italy Cell-based Assays Market, 2018 - 2021, USD Million
TABLE 81 Italy Cell-based Assays Market, 2022 - 2028, USD Million
TABLE 82 Italy Cell-based Assays Market by Application, 2018 - 2021, USD Million
TABLE 83 Italy Cell-based Assays Market by Application, 2022 - 2028, USD Million
TABLE 84 Italy Cell-based Assays Market by End-use, 2018 - 2021, USD Million
TABLE 85 Italy Cell-based Assays Market by End-use, 2022 - 2028, USD Million
TABLE 86 Italy Cell-based Assays Market by Products & Services, 2018 - 2021, USD Million
TABLE 87 Italy Cell-based Assays Market by Products & Services, 2022 - 2028, USD Million
TABLE 88 Rest of Europe Cell-based Assays Market, 2018 - 2021, USD Million
TABLE 89 Rest of Europe Cell-based Assays Market, 2022 - 2028, USD Million
TABLE 90 Rest of Europe Cell-based Assays Market by Application, 2018 - 2021, USD Million
TABLE 91 Rest of Europe Cell-based Assays Market by Application, 2022 - 2028, USD Million
TABLE 92 Rest of Europe Cell-based Assays Market by End-use, 2018 - 2021, USD Million
TABLE 93 Rest of Europe Cell-based Assays Market by End-use, 2022 - 2028, USD Million
TABLE 94 Rest of Europe Cell-based Assays Market by Products & Services, 2018 - 2021, USD Million
TABLE 95 Rest of Europe Cell-based Assays Market by Products & Services, 2022 - 2028, USD Million
TABLE 96 Key information – Becton, Dickinson and Company
TABLE 97 KEY INFORMATION – F. Hoffmann-La Roche Ltd.
TABLE 98 Key Information – Thermo Fisher Scientific, Inc.
TABLE 99 Key Information – Bio-Rad Laboratories, Inc.
TABLE 100 key information – Charles River Laboratories International, Inc.
TABLE 101 Key Information – Danaher Corporation
TABLE 102 key Information – Merck GrouP
TABLE 103 Key Information – Lonza Group AG
TABLE 104 Key Information – Corning Incorporated
TABLE 105 key Information – Promega Corporation
List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
FIG 4 Key Strategic Move: (Product Launches and Product Expansions : 2017, Jun – 2021, Jun) Leading Players
FIG 5 Recent strategies and developments: Becton, Dickinson and Company
FIG 6 Recent strategies and developments: F. Hoffmann-La Roche Ltd.
FIG 7 Recent strategies and developments: Thermo Fisher Scientific, Inc.
FIG 8 Recent strategies and developments: Bio-Rad Laboratories, Inc.
FIG 9 Recent strategies and developments: Charles River Laboratories
FIG 10 Recent strategies and developments: Promega Corp.